Please login to the form below

Not currently logged in
Email:
Password:

The Partners

This page shows the latest The Partners news and features for those working in and with pharma, biotech and healthcare.

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

Will also access Merck’s big-selling Neurobion and the Nasivin nasal decongestant range. ... P&G has won the unit despite interest from other partners, including Nestle, Novartis and reportedly Mylan, which as recently as last week was said to be in

Latest news

  • Amgen and Novartis migraine drug hits the mark again Amgen and Novartis migraine drug hits the mark again

    In the control group just under 14% of patients achieved a 50% reduction in migraine days. ... The two partners maintain that Aimovig is different to its rivals because they target CGRP itself, as opposed to the receptor pathway.

  • Health insurers will test blockchain for data handling Health insurers will test blockchain for data handling

    The overall aim is to make healthcare provider demographic data such as health records more accurate and reliable - and help drive out errors that the partners estimate can cost as much ... drug packs - which are due to come into effect in the US and EU

  • Sanofi’s PD-1 inhibitor starts EU review for skin cancer Sanofi’s PD-1 inhibitor starts EU review for skin cancer

    for launch”, with approval in the US possible before the end of the year. ... The two partners also see the drug as a foundation for a series of combination therapies for cancer with other checkpoint inhibitors and bispecific antibody drugs, but

  • Reig Jofre and LeanBio launch Syna Therapeutics Reig Jofre and LeanBio launch Syna Therapeutics

    Syna Therapeutics will have to finance 9m to carry out the early stages of development, with the founding partners both contributing the initial capital estimated at 2m. ... The new company has said it will also consider the entry of new financial or

  • Celgene bulks up pipeline again with $2.1bn Prothena deal Celgene bulks up pipeline again with $2.1bn Prothena deal

    TDP-43, which has been linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); and another target that the two partners are keeping under wraps for the moment. ... global rights that swell the total value of the deal to around

More from news
Approximately 1 fully matching, plus 557 partially matching documents found.

Latest Intelligence

  • A quest for innovative solutions A quest for innovative solutions

    A quest for innovative solutions. UCB looks to the future through a PRISM. ... Increase returns. UCB is one of the partners in a consortium that includes other EFPIA companies, universities, research organisations, public bodies, non-profit groups and

  • Deal Watch January 2018

    The companies were already partners having signed a $432m licensing deal in July 2016 for ex-US rights to Cx601 with double digit royalties due on net sales (DW Issue 73). ... Collaboration, licence. 830. Molecular Partners/ Allergan. Option exercise for

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    To allow us to act as true partners to the NHS, it is vital that we are able to deliver that support in an environment that recognises and rewards innovation, not ... The current PPRS scheme has delivered over £2bn to support the NHS since 2014.

  • Patient involvement in health technology assessment Patient involvement in health technology assessment

    A two-way process, where patient and carer representatives are treated as partners that support the development of patient involvement in HTA, as well as providing input, is vital to ensure ... One example is the annual programme delivered by the London

  • Patient recruitment and engagement standards Patient recruitment and engagement standards

    Many pharmaceutical companies who were sponsoring clinical trials, as well as their partners the clinical research organisations, were putting their efforts into estimating how successful their sites are likely to be. ... One of the key metrics was the

More from intelligence
Approximately 0 fully matching, plus 64 partially matching documents found.

Latest appointments

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    and the role our members play in developing new innovative medicines and vaccines. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”.

  • Lexington Communications bolsters team with a trio of new-hires Lexington Communications bolsters team with a trio of new-hires

    of the ever-changing health landscape to provide invaluable strategic advise and insider analysis to our existing and potential clients.”. ... Our new senior advisors will join a team that has the reputation of being one of the best in the market, and

  • Anish Mehta appointed CEO of new women's health business Anish Mehta appointed CEO of new women's health business

    Anish Mehta appointed CEO of new women's health business. Will head up the former Teva portoflio CVC Capital Partners recently acquired. ... London-based investment firm CVC Capital Partners has appointed Anish Mehta as chief executive officer of the

  • Bayer UK and Ireland appoints new CEO Bayer UK and Ireland appoints new CEO

    Bayer has appointed a new UK and Ireland CEO in the form of Lars Bruening, who moves to its Reading, UK base from Berlin where he was head of the pharma ... and the eighth largest in the world, as well as the progress made in individual markets also

  • Astellas appoints new senior VP Astellas appoints new senior VP

    of in-line products, late-stage development compounds and ongoing business evolution across the region. ... Astellas.”. “I’m confident she will make an immediate and positive impact on both the team in the Americas, as well as the patients and

More from appointments
Approximately 1 fully matching, plus 21 partially matching documents found.

Latest from PMHub

  • WE’s Make Twitter #COUGH campaign awarded with PM Society Bronze

    About:WE works with some of the most innovative companies on the planet — those focused on delivering the next big thing. ... Our playground is consumer, healthcare, social innovation and technology. Our fiercely independent mindset allows us the

  • The Heart of the Matter 7: Reality Dawns

    The best research partners can also help identify the right data sources to answer key questions and - crucially - encrypt and link data on the company's behalf so that we're ... The best partners will be those that combine specialist healthcare

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics